6/11/24 17:00 | 6/7/24 | PHIO | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | DO | P,CEO | P | 1 | 0.7400 | 0 | 1 | 5 | 21 | D | | | | | | | | | | | | | | |
6/10/24 17:00 | 6/6/24 | PHIO | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | DO | P,CEO | P | 1 | 0.7500 | 0 | 1 | 5 | 20 | D | | | | | | | | | | | | | | |
2/27/24 16:42 | 2/26/24 | PHIO | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | DO | P,CEO | P | 2 | 0.9100 | 0 | 3 | 15 | 19 | D | | | | | | | | | | | | | | |
6/15/23 17:00 | 6/14/23 | PHIO | Health | Drug | Pharmaceutical Preparations | Ferrara Robert L | MA | D | | P | 6 | 3.10 | 0 | 2 | 50 | 6 | D | | | | | | | | | | | | | | |
12/15/22 17:00 | 12/14/22 | PHIO | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | DO | Interim | P | 1 | 0.3900 | 0 | 2 | 3 | 75 | D | | | | | | | | | | | | | | |
12/8/22 16:30 | 12/7/22 | PHIO | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | DO | Interim | P | 1 | 0.3900 | 0 | 2 | 3 | 73 | D | | | | | | | | | | | | | | |
12/6/22 16:30 | 12/5/22 | PHIO | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | DO | Interim | P | 1 | 0.4300 | 0 | 2 | 3 | 71 | D | | | | | | | | | | | | | | |
12/5/22 16:30 | 12/2/22 | PHIO | Health | Drug | Pharmaceutical Preparations | Ferrara Robert L | MA | D | | P | 2 | 0.4082 | 0 | 5 | 20 | 30 | D | | | | | | | | | | | | | | |
11/29/22 16:30 | 11/25/22 | PHIO | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | DO | Interim | P.m | 1 | 0.4184 | 0 | 3 | 4 | 69 | D | | | | | | | | | | | | | | |
11/28/22 16:30 | 11/23/22 | PHIO | Health | Drug | Pharmaceutical Preparations | Ferrara Robert L | MA | D | | P | 1 | 0.4099 | 0 | 2 | 9 | 25 | D | | | | | | | | | | | | | | |
11/16/22 17:06 | 11/16/22 | PHIO | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | DO | Interim | P | 2 | 1,750.0 | 0 | 0 | New | 0 | D | | | | | | | | | | | | | | |
8/17/21 09:11 | 8/16/21 | PHIO | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | DO | P,CEO | P | 10 | 1.63 | 0 | 6 | 7 | 95 | D | | | | | | | | | | | | | | |
3/5/21 07:05 | 3/4/21 | PHIO | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | DO | P,CEO | P | 5 | 2.56 | 0 | 2 | 2 | 89 | D | | | | | | | | | | | | | | |
3/3/21 21:05 | 3/3/21 | PHIO | Health | Drug | Pharmaceutical Preparations | Ferrara Robert L | MA | D | | P | 2 | 3.15 | 0 | 1 | 6 | 13 | D | | | | | | | | | | | | | | |
3/3/21 21:00 | 3/3/21 | PHIO | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | DO | P,CEO | P | 8 | 3.03 | 0 | 3 | 3 | 87 | D | | | | | | | | | | | | | | |
8/19/20 17:00 | 8/19/20 | PHIO | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | O | P,CEO | P | 5 | 2.50 | 0 | 2 | 14 | 16 | D | | | | | | | | | | | | | | |
10/2/17 15:44 | 10/2/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 4 | 0.4475 | 0 | 10 | 7 | 148 | D | | | | | | | | | | | | | | |
9/7/17 20:17 | 9/5/17 | RXII | Health | Drug | Pharmaceutical Preparations | Eliseev Alexey | MA | O | Chief Bu | S.m | -95 | 0.5368 | 0 | -177 | -16 | 950 | D | | | | | | | | | | | | | | |
9/1/17 20:33 | 9/1/17 | RXII | Health | Drug | Pharmaceutical Preparations | Eliseev Alexey | MA | O | Chief Bu | S | -13 | 0.5682 | 0 | -23 | -2 | 1,127 | D | | | | | | | | | | | | | | |
8/24/17 11:55 | 8/24/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 5 | 0.5483 | 0 | 10 | 8 | 138 | D | | | | | | | | | | | | | | |
6/26/17 08:23 | 6/23/17 | RXII | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | O | Chief De | P | 2 | 0.6200 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
6/22/17 11:49 | 6/22/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 6 | 0.6250 | 0 | 10 | 9 | 128 | D | | | | | | | | | | | | | | |
4/26/17 10:52 | 4/26/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 6 | 0.6480 | 1 | 10 | 9 | 118 | D | -90 | -68 | -45 | -6 | -17 | -20 | -13 | -6 | 5 | -2 | | | | |
3/20/17 09:16 | 3/17/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 8 | 0.7692 | 1 | 10 | 10 | 108 | D | -94 | -73 | -65 | -44 | 18 | 11 | 0 | -1 | -3 | -6 | -18 | | | |
2/21/17 07:11 | 2/17/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 7 | 0.6931 | 1 | 10 | 11 | 98 | D | -94 | -76 | -71 | -44 | -4 | 8 | -4 | -3 | 1 | -1 | 6 | | | |
2/8/17 11:43 | 2/8/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 7 | 0.6850 | 1 | 10 | 13 | 88 | D | -94 | -75 | -70 | -33 | 4 | 5 | 10 | 12 | -1 | -3 | 13 | -27 | | |
1/26/17 08:05 | 1/25/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 7 | 0.6966 | 1 | 10 | 15 | 78 | D | -94 | -77 | -71 | -39 | -57 | -7 | -7 | 3 | -3 | -10 | 0 | -2 | | |
1/19/17 13:48 | 1/19/17 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 7 | 0.6949 | 1 | 10 | 17 | 68 | D | -94 | -74 | -69 | -39 | -48 | -5 | -4 | 0 | -6 | -1 | 3 | 0 | | |
4/2/15 11:15 | 4/2/15 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 4 | 0.7192 | 0 | 5 | 7 | 77 | D | -91 | -84 | -65 | -55 | -41 | -36 | -33 | -7 | 4 | 6 | -5 | -26 | -47 | -62 |
2/18/15 09:21 | 2/17/15 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 5 | 1.17 | 0 | 4 | 6 | 72 | D | -70 | -75 | -57 | -39 | -29 | -6 | -5 | -10 | 2 | -3 | 5 | -56 | -68 | -74 |
2/11/15 09:41 | 2/10/15 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 2 | 1.24 | 0 | 2 | 3 | 68 | D | -58 | -74 | -52 | -34 | -21 | 2 | 16 | 5 | 0 | -8 | -12 | -54 | -68 | -77 |
1/23/15 08:50 | 1/22/15 | RXII | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | D | | P | 6 | 1.20 | 0 | 5 | 333 | 7 | D | -48 | -73 | -51 | -43 | -40 | -24 | -21 | -2 | -3 | -5 | -8 | -45 | -61 | -75 |
1/20/15 11:56 | 1/20/15 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 10 | 1.03 | 0 | 10 | 18 | 66 | D | -47 | -74 | -51 | -32 | -36 | -23 | -19 | -9 | -14 | -2 | -6 | -41 | -61 | -78 |
12/31/14 08:41 | 12/30/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 4 | 1.59 | 0 | 3 | 5 | 56 | D | -31 | -45 | -48 | -22 | -14 | -23 | -19 | -3 | 3 | -3 | -30 | -55 | -66 | -75 |
10/14/14 09:36 | 10/13/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 5 | 1.68 | 0 | 3 | 6 | 54 | D | -51 | -45 | -52 | -33 | -49 | -22 | -7 | -19 | 1 | 24 | 9 | -20 | -58 | -64 |
9/23/14 13:21 | 9/19/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 10 | 2.20 | 0 | 5 | 10 | 51 | I | -36 | -35 | -56 | -23 | -13 | -32 | 0 | 4 | -5 | -11 | -6 | -30 | -60 | -81 |
9/16/14 15:31 | 9/16/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 10 | 2.08 | 0 | 5 | 12 | 46 | I | -37 | -38 | -62 | -29 | -12 | -13 | -37 | -10 | -4 | 4 | -23 | -8 | -46 | -79 |
9/15/14 12:46 | 9/15/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 22 | 2.18 | 0 | 10 | 32 | 41 | D | -30 | -34 | -58 | -25 | -7 | -7 | -37 | -35 | -5 | -3 | -28 | -13 | -48 | -79 |
8/4/14 16:03 | 7/31/14 | RXII | Health | Drug | Pharmaceutical Preparations | Advanced Rna Technologies, LLC | MA | H | No longe | P | 1 | 2.48 | 0 | 0 | 0 | 1,222 | D | -36 | -38 | -46 | -26 | -14 | -4 | 0 | 0 | 0 | 1 | 34 | -17 | -56 | -83 |
7/17/14 09:57 | 7/15/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 3 | 2.50 | 0 | 1 | 3 | 31 | D | 413 | -50 | -52 | -28 | -14 | -18 | -14 | -2 | 1 | 1 | 13 | -31 | -41 | -79 |
7/9/14 15:23 | 7/9/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 4 | 2.57 | 0 | 1 | 5 | 30 | D | -55 | -55 | -16 | -21 | -9 | -15 | -12 | -10 | -4 | -7 | -7 | -29 | -42 | -82 |
7/2/14 14:22 | 7/2/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 6 | 2.86 | 0 | 2 | 8 | 29 | D | 17 | -49 | 5 | -31 | 4 | -5 | 2 | -2 | 0 | -14 | -16 | -33 | -48 | -82 |
6/26/14 11:46 | 6/25/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 2 | 3.01 | 0 | 1 | 2 | 27 | D | 29 | -49 | 4 | -33 | -3 | 4 | -3 | 3 | 1 | -1 | -18 | -28 | -47 | -80 |
6/19/14 13:15 | 6/19/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 6 | 2.98 | 0 | 2 | 8 | 26 | D | 27 | -49 | 7 | -49 | 0 | 9 | 3 | -2 | -3 | -1 | -18 | -28 | -38 | -85 |
6/9/14 13:32 | 6/9/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 3 | 3.05 | 0 | 1 | 4 | 24 | D | 17 | -51 | -1 | -51 | -19 | -2 | 4 | 1 | 0 | 5 | -9 | 13 | -35 | -84 |
6/5/14 07:48 | 6/4/14 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 6 | 2.94 | 0 | 2 | 9 | 23 | D | 19 | -52 | -8 | -51 | -28 | -8 | -3 | 6 | 1 | 9 | 3 | 29 | -34 | -86 |
11/1/13 13:05 | 10/30/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P.m | 3 | 3.17 | 0 | 1 | 5 | 21 | D | | 7 | -52 | -26 | -12 | 0 | -9 | -1 | 0 | -3 | 2 | 46 | 9 | -35 |
10/24/13 09:24 | 10/23/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 3 | 3.34 | 0 | 1 | 5 | 20 | D | | 6 | -47 | -33 | -5 | -3 | -5 | -5 | -2 | -7 | -7 | 27 | 10 | -42 |
10/22/13 16:31 | 10/18/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P.m | 2 | 3.42 | 0 | 1 | 4 | 19 | D | | 7 | -47 | -21 | -2 | 2 | 9 | 0 | 0 | -8 | -10 | 33 | 18 | -35 |
10/16/13 16:10 | 10/14/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P.m | 1 | 3.53 | 0 | 0 | 2 | 18 | D | | 4 | -52 | -27 | -5 | 0 | 1 | 9 | 0 | -4 | -9 | 41 | -2 | -51 |
10/9/13 15:21 | 10/9/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 3 | 3.15 | 0 | 1 | 6 | 18 | D | | -2 | -57 | -42 | -8 | -3 | -1 | -2 | -13 | 4 | -12 | 11 | 8 | -39 |
10/7/13 09:34 | 10/3/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P.m | 1 | 3.50 | 0 | 0 | 2 | 17 | D | | 6 | -55 | -42 | -5 | -2 | -1 | 1 | 0 | -13 | -14 | -8 | -3 | -46 |
10/2/13 11:36 | 9/30/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.42 | 0 | 0 | 2 | 17 | D | | 11 | -57 | -40 | -8 | -3 | -1 | -1 | 2 | -1 | -10 | -16 | 27 | -43 |
9/26/13 12:17 | 9/24/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P.m | 1 | 3.50 | 0 | 0 | 2 | 17 | D | | 7 | -58 | -40 | -10 | -1 | -1 | 1 | -1 | 0 | -7 | -19 | 30 | -40 |
9/24/13 09:32 | 9/23/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.49 | 0 | 0 | 1 | 16 | D | | 6 | -60 | -40 | -10 | -3 | -1 | 1 | 0 | 0 | -4 | -15 | 40 | -38 |
9/23/13 09:56 | 9/20/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.52 | 0 | 0 | 2 | 16 | D | | -3 | -57 | -42 | -11 | 2 | -2 | -2 | 1 | -2 | 1 | -16 | 50 | -35 |
9/19/13 09:43 | 9/18/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.49 | 0 | 0 | 1 | 16 | D | | 5 | -52 | -42 | -13 | -7 | -5 | -1 | 4 | 1 | 1 | -20 | 69 | -36 |
9/17/13 12:35 | 9/17/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.55 | 0 | 0 | 1 | 15 | D | | -1 | -64 | -40 | -11 | -9 | 0 | 0 | 0 | -1 | -1 | -19 | 63 | -41 |
9/16/13 09:50 | 9/13/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.58 | 0 | 0 | 1 | 15 | D | | 2 | -64 | -41 | -15 | -5 | -5 | -2 | 1 | -1 | 0 | -17 | 62 | -38 |
9/12/13 09:23 | 9/10/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P.m | 2 | 3.60 | 0 | 1 | 3 | 15 | D | | -1 | -59 | -41 | -15 | -7 | 4 | -1 | -1 | -2 | -9 | -16 | 55 | -36 |
9/3/13 09:27 | 8/30/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.36 | 0 | 0 | 2 | 15 | D | | -13 | -25 | -43 | -26 | -13 | -11 | -8 | 6 | 7 | 1 | -9 | 69 | -2 |
8/30/13 10:42 | 8/29/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.48 | 0 | 0 | 3 | 14 | D | | -9 | -24 | -41 | -18 | -9 | -5 | -9 | -4 | 1 | -1 | -12 | 50 | -16 |
8/30/13 10:28 | 8/29/13 | RXII | Health | Drug | Pharmaceutical Preparations | Lockshin Curtis | MA | D | | P | 4 | 3.70 | 0 | 1 | New | 1 | D | | -9 | -24 | -41 | -18 | -9 | -5 | -9 | -4 | 1 | -1 | -12 | 50 | -16 |
8/29/13 10:06 | 8/28/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.70 | 0 | 0 | 3 | 14 | D | | 0 | -21 | -37 | -12 | -6 | 4 | 2 | -5 | -5 | -9 | -18 | 60 | -24 |
8/28/13 10:23 | 8/27/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 0 | 3.70 | 0 | 0 | 1 | 13 | D | | 1 | -21 | -39 | -23 | -8 | -4 | 6 | 2 | 0 | -6 | -16 | 63 | -28 |
8/27/13 09:36 | 8/26/13 | RXII | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | D | | P | 2 | 3.90 | 0 | 1 | 50 | 2 | D | | 0 | -21 | -35 | -21 | -3 | 2 | 3 | -6 | -8 | -10 | -21 | 54 | -35 |
8/26/13 10:18 | 8/23/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.71 | 0 | 0 | 2 | 13 | D | | -5 | -32 | -39 | -28 | -8 | -5 | -2 | 6 | -8 | -5 | -16 | 64 | -32 |
8/23/13 09:19 | 8/22/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.62 | 0 | 0 | 2 | 13 | D | | -4 | -32 | -42 | -40 | -16 | -11 | -4 | 7 | 3 | 1 | -12 | 78 | -28 |
8/22/13 09:29 | 8/21/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 3 | 3.80 | 0 | 1 | 6 | 13 | D | | 7 | -23 | -37 | -35 | -5 | -3 | -1 | -9 | -1 | -8 | -21 | 26 | -35 |
8/21/13 09:59 | 8/20/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 3 | 3.80 | 0 | 1 | 6 | 12 | D | | 14 | -32 | -38 | -36 | -10 | -4 | -1 | 1 | -2 | -4 | -19 | 25 | -34 |
8/20/13 09:50 | 8/19/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 3.72 | 0 | 0 | 3 | 11 | D | | 6 | -40 | -40 | -38 | -14 | -10 | -7 | 4 | 8 | -3 | -17 | 25 | -31 |
8/6/13 11:25 | 8/5/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P.m | 4 | 4.02 | 0 | 1 | 10 | 11 | D | | 11 | 67 | -33 | -32 | -19 | -20 | -4 | 0 | -3 | -8 | -24 | 10 | -38 |
8/5/13 16:43 | 8/5/13 | RXII | Health | Drug | Pharmaceutical Preparations | Bitterman Robert J | MA | D | | P | 4 | 4.08 | 0 | 1 | New | 1 | D | | 15 | 84 | -34 | -31 | -19 | -16 | -2 | 1 | -2 | -10 | -23 | 11 | -37 |
7/31/13 16:15 | 7/31/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 1 | 4.02 | 0 | 0 | 2 | 10 | D | | 12 | 80 | -33 | -29 | -28 | -3 | -16 | -4 | -4 | -10 | -26 | 14 | -40 |
7/31/13 11:35 | 7/31/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 2 | 4.10 | 0 | 1 | 5 | 10 | D | | 12 | 80 | -33 | -29 | -28 | -3 | -16 | -1 | -5 | -11 | -27 | 13 | -41 |
7/30/13 10:01 | 7/29/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 2 | 4.54 | 0 | 1 | 6 | 9 | D | | 12 | 102 | -33 | -24 | -22 | 7 | -7 | -7 | -12 | -19 | -30 | 8 | -45 |
7/29/13 13:34 | 7/26/13 | RXII | Health | Drug | Pharmaceutical Preparations | Cauwenbergh Geert | MA | DO | P,CEO | P | 2 | 4.87 | 0 | 1 | 6 | 9 | D | | 22 | 118 | -27 | -18 | -20 | 1 | 10 | -6 | -14 | -19 | -32 | -2 | -48 |
5/2/13 18:57 | 4/30/13 | RXII | Health | Drug | Pharmaceutical Preparations | Galena Biopharma, Inc. | OR | T | | S.m | -212 | 0.1954 | 0 | -1,084 | -3 | 32,393 | D | | | 92 | 144 | -21 | -24 | -18 | -14 | 2 | -3 | -3 | -35 | -55 | -53 |